$2.59 Billion is the total value of HealthCor Management, L.P.'s 54 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 428.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HZNP | Buy | HORIZON THERAPEUTICS PUB L | $154,938,000 | +11.4% | 2,118,090 | +18.3% | 5.98% | +7.3% |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $137,855,000 | +39.8% | 583,290 | +61.0% | 5.32% | +34.7% |
| COO | Buy | COOPER COS INC | $125,574,000 | +54.2% | 345,630 | +43.1% | 4.84% | +48.6% |
| MRVI | New | MARAVAI LIFESCIENCES HLDGS I | $87,929,000 | – | 3,134,712 | +100.0% | 3.39% | – |
| BIO | New | BIO RAD LABS INCcl a | $81,658,000 | – | 140,080 | +100.0% | 3.15% | – |
| BMY | Buy | BRISTOL-MYERS SQUIBB CO | $80,496,000 | +963.9% | 1,297,700 | +934.0% | 3.10% | +924.4% |
| HOLX | New | HOLOGIC INC | $74,089,000 | – | 1,017,280 | +100.0% | 2.86% | – |
| MCK | New | MCKESSON CORP | $73,533,000 | – | 422,800 | +100.0% | 2.84% | – |
| JNJ | New | JOHNSON & JOHNSON | $68,462,000 | – | 435,010 | +100.0% | 2.64% | – |
| HAE | New | HAEMONETICS CORP | $67,256,000 | – | 566,370 | +100.0% | 2.59% | – |
| SYNH | New | SYNEOS HEALTH INCcl a | $54,049,000 | – | 793,320 | +100.0% | 2.08% | – |
| QQQ | New | INVESCO QQQ TRput | $43,924,000 | – | 140,000 | +100.0% | 1.69% | – |
| AGIO | New | AGIOS PHARMACEUTICALS INC | $43,203,000 | – | 997,070 | +100.0% | 1.67% | – |
| LIVN | New | LIVANOVA PLC | $40,787,000 | – | 616,030 | +100.0% | 1.57% | – |
| NVST | New | ENVISTA HOLDINGS CORPORATION | $35,055,000 | – | 1,039,290 | +100.0% | 1.35% | – |
| VTR | New | VENTAS INC | $32,285,000 | – | 658,350 | +100.0% | 1.24% | – |
| EW | Buy | EDWARDS LIFESCIENCES CORP | $29,303,000 | +64.0% | 321,200 | +43.5% | 1.13% | +58.0% |
| HZNP | New | HORIZON THERAPEUTICS PUB Lcall | $29,260,000 | – | 400,000 | +100.0% | 1.13% | – |
| CTLT | New | CATALENT INC | $28,125,000 | – | 270,250 | +100.0% | 1.08% | – |
| SPY | New | SPDR S&P 500 ETF TRput | $28,041,000 | – | 75,000 | +100.0% | 1.08% | – |
| OHI | New | OMEGA HEALTHCARE INVS INC | $27,999,000 | – | 770,910 | +100.0% | 1.08% | – |
| SNDX | Buy | SYNDAX PHARMACEUTICALS INC | $23,809,000 | +4912.4% | 1,070,550 | +3224.7% | 0.92% | +4731.6% |
| WELL | New | WELLTOWER INC | $23,077,000 | – | 357,120 | +100.0% | 0.89% | – |
| IWM | New | ISHARES TRput | $20,586,000 | – | 105,000 | +100.0% | 0.79% | – |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $19,486,000 | +1653.9% | 222,210 | +1422.0% | 0.75% | +1606.8% |
| CRIS | New | CURIS INC | $19,446,000 | – | 2,374,370 | +100.0% | 0.75% | – |
| CNMD | New | CONMED CORP | $11,200,000 | – | 100,000 | +100.0% | 0.43% | – |
| ALXN | New | ALEXION PHARMACEUTICALS INC | $9,582,000 | – | 61,330 | +100.0% | 0.37% | – |
| DCPH | New | DECIPHERA PHARMACEUTICALS IN | $7,945,000 | – | 139,210 | +100.0% | 0.31% | – |
| FOLD | New | AMICUS THERAPEUTICS INCput | $5,773,000 | – | 250,000 | +100.0% | 0.22% | – |
| CERT | New | CERTARA INC | $5,058,000 | – | 150,000 | +100.0% | 0.20% | – |
| BIIB | New | BIOGEN INC | $2,341,000 | – | 9,560 | +100.0% | 0.09% | – |
| AMRN | New | AMARIN CORP PLCspons adr new | $1,921,000 | – | 392,760 | +100.0% | 0.07% | – |
| CI | New | CIGNA CORP NEW | $1,770,000 | – | 8,502 | +100.0% | 0.07% | – |
| ITCI | New | INTRA CELLULAR THERAPIES INC | $1,754,000 | – | 55,150 | +100.0% | 0.07% | – |
| FPRX | New | FIVE PRIME THERAPEUTICS INC | $1,479,000 | – | 86,930 | +100.0% | 0.06% | – |
| ANIK | New | ANIKA THERAPEUTICS INC | $920,000 | – | 20,320 | +100.0% | 0.04% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-16
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HCA HOLDINGS INC | 27 | Q1 2022 | 6.2% |
| ZIMMER HLDGS INC | 26 | Q2 2022 | 9.3% |
| DANAHER CORPORATION | 26 | Q3 2022 | 5.6% |
| NEUROCRINE BIOSCIENCES INC | 26 | Q4 2022 | 7.8% |
| UNITEDHEALTH GROUP INC | 24 | Q3 2022 | 6.4% |
| VERTEX PHARMACEUTICALS INC | 24 | Q3 2021 | 5.3% |
| HUMANA INC | 22 | Q3 2022 | 6.6% |
| BRISTOL-MYERS SQUIBB CO | 22 | Q3 2022 | 9.2% |
| BIOGEN INC | 21 | Q3 2022 | 8.5% |
| LABORATORY CORP AMER HLDGS | 20 | Q2 2020 | 8.3% |
View HealthCor Management, L.P.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| CareView Communications Inc | May 26, 2023 | 186,970,000 | 32.0% |
| Research Alliance Corp. IISold out | February 14, 2023 | 0 | 0.0% |
| ARYA Sciences Acquisition Corp IVSold out | February 14, 2022 | 0 | 0.0% |
| Aurinia Pharmaceuticals Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| MADRIGAL PHARMACEUTICALS, INC.Sold out | February 14, 2022 | 0 | 0.0% |
| Medicus Sciences Acquisition Corp.Sold out | February 14, 2022 | 0 | 0.0% |
| Arcturus Therapeutics Holdings Inc.Sold out | February 12, 2021 | 0 | 0.0% |
| Intersect ENT, Inc.Sold out | February 12, 2021 | 0 | 0.0% |
| NEVRO CORP | February 12, 2021 | 156,046 | 0.5% |
| ViewRay, Inc.Sold out | February 12, 2021 | 0 | 0.0% |
View HealthCor Management, L.P.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2023-05-26 |
| 4 | 2023-05-26 |
| SC 13D/A | 2023-05-26 |
| 4 | 2023-04-04 |
| 4 | 2023-04-04 |
| SC 13D/A | 2023-04-03 |
| 13F-HR | 2023-02-15 |
| SC 13G/A | 2023-02-14 |
| 4 | 2023-01-04 |
| 4 | 2023-01-04 |
View HealthCor Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.